Journal article icon

Journal article

Risk factors for mortality and severe morbidity in fetuses with normal late third‐trimester scan: population‐based cohort study

Abstract:
Objective: To identify antepartum risk factors for fetal or neonatal mortality and severe morbidity in pregnancies undergoing a universal late third‐trimester ultrasound scan in which there was no ultrasound evidence of small‐for‐gestational age (SGA) or fetal growth restriction (FGR). Methods: This was a retrospective population‐based cohort study of singleton, non‐anomalous term pregnancies undergoing a universal ultrasound scan at 35 + 1 to 36 + 6 weeks' gestation at a major UK maternity unit, over a period of 7 years. Pregnancies complicated by SGA or FGR were excluded. The outcomes were: stillbirth; severe composite adverse outcome, including extended perinatal mortality and severe morbidity; and severe SGA, defined as birth weight < 3rd centile. Potential clinical, demographic and ultrasonographic risk factors were evaluated using univariate and multivariate logistic regression analysis. Results: The study population of 40 169 pregnancies comprised 88.9% of all eligible term pregnancies. There were 48 (0.1%) stillbirths, 221 (0.6%) cases of severe composite adverse outcome and 295 (0.7%) cases of severe SGA. Five (10.4%) stillborn infants weighed < 10th centile at delivery (adjusted odds ratio (aOR), 2.70 (95% CI, 1.06–6.92)); 23 (47.9%) cases of stillbirth were considered unexplained. Pre‐eclampsia was associated with stillbirth (odds ratio, 4.46 (95% CI, 1.99–9.96)) but no other antenatal factors, including ultrasound measures of fetal growth, showed a significant association with this outcome. Pre‐eclampsia constituted 9.6% of the population‐attributable fraction for stillbirth. Severe composite adverse outcome was associated only with pre‐existing diabetes (aOR, 2.82 (95% CI, 1.02–7.85)) and nulliparity (aOR, 1.56 (95% CI, 1.19–2.04)). Conclusions: The potential to predict mortality and severe morbidity in fetuses without ultrasound evidence of SGA and FGR is poor. In these fetuses, the role of ultrasound in further reducing adverse outcomes at term is limited. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1002/uog.29256

Authors

More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-0526-6329
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-1606-7213
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-4781-9473
More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Institution:
University of Oxford
Role:
Author


Publisher:
Wiley
Journal:
Ultrasound in Obstetrics & Gynecology More from this journal
Volume:
66
Issue:
1
Pages:
56-64
Publication date:
2025-06-16
Acceptance date:
2025-04-17
DOI:
EISSN:
1469-0705
ISSN:
0960-7692


Language:
English
Keywords:
Pubs id:
2241229
Local pid:
pubs:2241229
Source identifiers:
3027970
Deposit date:
2025-06-16
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP